Evon S. Dellon, MD, MPH, professor in the department of medicine’s division of gastroenterology and hepatology, discussed the Phase 3 LIBERTY-EoE-TREET study for Dupixent (Dupilumab). The results were presented at the American Academy of Allergy, Asthma & Immunology’s Annual Meeting.